| Supplemental Schedule of Non-Cash Investing / Financing Activities |
16. Supplemental Schedule of Non-Cash Investing / Financing Activities The following schedule summarizes the non-cash investing and financing activities of the Company for the nine months ended September 30, 2026 and 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
Consolidation of Joint Ventures: |
|
|
|
|
|
|
Real estate assets, net |
|
$ |
- |
|
|
$ |
76,488 |
|
Mortgages payable, net |
|
$ |
- |
|
|
$ |
(31,425 |
) |
Deconsolidation of Joint Venture: |
|
|
|
|
|
|
Real estate assets, net |
|
$ |
(48,779 |
) |
|
$ |
- |
|
Investments in and advances to other investments |
|
$ |
48,727 |
|
|
$ |
- |
|
Other assets |
|
$ |
(690 |
) |
|
$ |
- |
|
Other liabilities |
|
$ |
512 |
|
|
$ |
- |
|
Proceeds deposited in escrow through sale of real estate interests |
|
$ |
27,827 |
|
|
$ |
10,908 |
|
Capital expenditures accrual |
|
$ |
56,114 |
|
|
$ |
45,853 |
|
Conversion of other financing receivable to cost method investment |
|
$ |
2,423 |
|
|
$ |
- |
|
Lease liabilities arising from obtaining operating right-of-use assets |
|
$ |
1,424 |
|
|
$ |
7,377 |
|
Decrease in noncontrolling interests’ carrying amount, net (including redeemable) |
|
$ |
(3,221 |
) |
|
$ |
(340 |
) |
Surrender of restricted common stock/units |
|
$ |
6,394 |
|
|
$ |
11,687 |
|
Declaration of dividends/distributions paid in succeeding period |
|
$ |
5,437 |
|
|
$ |
6,364 |
|
The following table provides a reconciliation of cash, cash equivalents and restricted cash recorded on the Company’s Condensed Consolidated Balance Sheets to the Company’s Condensed Consolidated Statements of Cash Flows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2026 |
|
|
As of December 31, 2025 |
|
Cash and cash equivalents |
|
$ |
543,744 |
|
|
$ |
211,648 |
|
Restricted cash |
|
|
1,172 |
|
|
|
1,146 |
|
Total cash, cash equivalents and restricted cash |
|
$ |
544,916 |
|
|
$ |
212,794 |
|
|